Ndea
Building AGI that can innovate.
Winter 2026ActiveIndustrialsArtificial IntelligenceDeep LearningHard TechRemote WorkMLRemote
Company
https://ndea.comNdea is building frontier AI systems that blend intuitive pattern recognition and formal reasoning into a unified architecture.
# AI for Scientific Advancement
Unlike all life before us, humanity's ascent is a story of ingenuity, not just biological evolution. Our progress has been driven by the curiosity to acquire knowledge, the ability to pass it on, and an intrinsic drive to innovate. We build technology which gives us leverage beyond our biology.
We stand at the top of a knowledge and technology colossus that we collectively created over the past ten thousand generations. Scientific progress has helped us overcome burdens that long defined human life — famines, plagues, and widespread illiteracy. Science will continue to redefine the boundaries of the human condition.
Today, the acceleration of scientific progress hinges on one factor: AI capable of independent invention and discovery. This capacity is the gateway to advancements beyond our wildest imagination.
# A New Research Lab
We're starting Ndea — an AI research and science lab. The name - like 'idea' with an 'n' - is inspired by the Greek concepts ennoia (intuitive understanding) and dianoia (logical reasoning), capturing our first goal to merge deep learning with program synthesis.
Ndea is entirely focused on developing and operationalizing AGI to realize unprecedented scientific progress in our lifetime for the benefit of all current and future generations.
Building AGI alone is a monumental undertaking, but our mission is even bigger. We're creating a factory for rapid scientific advancement — a factory capable of inventing and commercializing N ideas.
From our vantage point today, we see many 'known' frontiers like self-driving vehicles, drug discovery, sustainable energy, robotics, and space exploration. While AGI will benefit all of these, the most exciting adventure lies in the 'unknown'. AGI promises discoveries and progress we cannot imagine today.
Verdict
Medium Signal
Market Opportunity
AGI for scientific advancement is an enormous theoretical TAM (drug discovery, energy, robotics alone are multi-trillion dollar markets), but the ICP is undefined and monetization path is entirely unclear. This is a research lab, not a product company, so traditional market sizing frameworks barely apply.
High Signal
Founder Signal
Francois Chollet is the creator of Keras (the most widely used deep learning framework), invented the ARC benchmark for measuring general intelligence, and spent years as a Staff Engineer at Google. Mike Knoop is co-founder of Zapier, a company that scaled to hundreds of millions in ARR. Combined, these two founders represent one of the most credentialed AI research + startup execution pairings imaginable.
Low Signal
Competition
Competing directly with OpenAI, Anthropic, DeepMind, and every frontier lab — all of which are also exploring program synthesis and neuro-symbolic approaches. Ndea's own website acknowledges 'every frontier AI lab is now starting to explore' program synthesis. The differentiation claim (program synthesis as equally important as deep learning) is a research bet, not a defensible moat.
Low Signal
Product
Pure research lab positioning with no product, no customers, no revenue, no demo, no API docs. Website is entirely a manifesto about AGI via program synthesis. No traction signals whatsoever — just tagline and hiring page.
OverallB Tier
Chollet and Knoop are a genuinely exceptional founding pair — Keras creator plus Zapier co-founder is a rare combination of research credibility and proven startup execution. However, this is currently a research lab with a manifesto, zero product, zero customers, and a technically speculative thesis competing head-on with the best-funded AI labs in history. The program synthesis bet is intellectually serious (Chollet has spent years on ARC) but it's a long-odds research gamble, not a startup with a near-term revenue path. The founder quality alone justifies a B, but without any product or traction signals, and with the most formidable competitive landscape in tech, this is high-upside/high-risk research infrastructure, not a near-term commercial winner.
